What is the recommended evaluation and management for an allergic cough caused by post‑nasal drip from allergic rhinitis or asthma?

Allergic Cough: Evaluation and Management

First-Line Treatment

For allergic cough caused by post-nasal drip from allergic rhinitis, start immediately with a first-generation antihistamine/decongestant combination (such as chlorpheniramine plus sustained-release pseudoephedrine) PLUS an intranasal corticosteroid (fluticasone 100-200 mcg daily). 1 This dual-therapy approach is the most effective evidence-based treatment, with most patients showing improvement within days to 2 weeks. 1

Why This Combination Works

• First-generation antihistamines are superior to newer non-sedating antihistamines because their anticholinergic properties directly reduce secretions and have central antitussive effects. 1
• Intranasal corticosteroids are the most effective monotherapy for allergic rhinitis and work synergistically with antihistamines to control both inflammation and secretions. 1, 2
• Newer-generation antihistamines (cetirizine, loratadine, fexofenadine) are ineffective for non-allergic causes of post-nasal drip cough and should not be used as monotherapy. 1

Dosing Strategy to Minimize Side Effects

• Start with once-daily dosing at bedtime for a few days before increasing to twice-daily therapy to minimize sedation. 1
• Common side effects include dry mouth and transient dizziness; monitor for insomnia, urinary retention, tachycardia, worsening hypertension, and increased intraocular pressure in glaucoma patients. 1
• Monitor blood pressure after initiating decongestant therapy, as these agents can worsen hypertension. 1

---

Diagnostic Considerations

Clinical Diagnosis

• Allergic rhinitis presents with the "itching triad" (nose, palate, eyes), sneezing, and extranasal involvement—features that distinguish it from non-allergic rhinitis. 3, 2
• Approximately 20% of patients have "silent" post-nasal drip with no obvious symptoms (no visible drainage, throat clearing, or pharyngeal cobblestoning) yet still respond to treatment. 1
• The diagnosis is confirmed by therapeutic response, not by symptoms or physical findings alone. 1

When to Perform Allergy Testing

• Allergy testing (skin or serum-specific IgE) should be considered when:
  • Perennial rhinitis is suspected but the history is unclear. 3
  • Response to empiric therapy is inadequate after 2-4 weeks. 1
  • Identification of specific allergens is needed for targeted avoidance or immunotherapy. 1
• Testing for indoor allergens (dust mite, animal danders, indoor mold) is particularly valuable in perennial cases. 3

Exclude GERD as a Mimic

• GERD frequently mimics upper airway cough syndrome with similar pharyngeal symptoms and can coexist with post-nasal drip. 3, 1
• If cough persists despite adequate upper airway treatment, initiate a proton pump inhibitor (omeprazole 20-40 mg twice daily before meals) for at least 8 weeks plus dietary modifications. 1

---

Stepwise Escalation for Inadequate Response

After 1-2 Weeks: Add Intranasal Corticosteroids (if not already started)

• If the antihistamine-decongestant combination alone is insufficient, add fluticasone 100-200 mcg daily for a 1-month trial. 1
• A single randomized controlled trial showed intranasal steroids given for 2 weeks are effective in allergic rhinitis-related cough. 1

After 2 Weeks: Evaluate for Asthma or Cough-Variant Asthma

• If symptoms persist despite adequate upper airway treatment for 2 weeks, proceed with sequential evaluation for asthma/non-asthmatic eosinophilic bronchitis. 1
• Consider bronchial provocation testing (methacholine challenge) or an empiric trial of inhaled corticosteroids. 1, 4
• Post-nasal drip symptoms significantly prolong cough duration in patients with cough-variant asthma (19.5 vs. 11.0 days), so treat both conditions simultaneously. 5

Alternative Agents for Specific Situations

• Ipratropium bromide nasal spray (42 mcg per spray, 2 sprays per nostril 4 times daily) is an alternative for patients with contraindications to decongestants, providing anticholinergic drying effects without systemic cardiovascular side effects. 1
• Oral leukotriene inhibitors (montelukast) decrease symptoms of allergic rhinitis and can be added for refractory cases. 1
• High-volume saline nasal irrigation (150 mL) mechanically removes secretions and improves mucociliary function; it is more effective than saline spray. 1

---

Treatment Timeline and Monitoring

• Most patients see improvement within days to 2 weeks of initiating therapy. 1
• Complete resolution may take several weeks to a few months. 1
• Maintain all partially effective treatments rather than discontinuing them prematurely, as upper airway cough syndrome, asthma, and GERD together account for approximately 90% of chronic cough cases in nonsmokers with normal chest radiographs. 1

---

Critical Pitfalls to Avoid

• Do not overlook "silent" upper airway cough syndrome as a potential cause before investigating less common etiologies. 3, 1
• Do not use topical nasal decongestants (oxymetazoline, xylometazoline) for more than 3-5 consecutive days due to the risk of rhinitis medicamentosa (rebound congestion). 1
• Do not prescribe antibiotics during the first week of symptoms, even with purulent nasal discharge, as these findings cannot distinguish viral from bacterial sinusitis. 1
• Do not rely solely on physical examination—the absence of visible post-nasal drainage or cobblestoning does not rule out upper airway cough syndrome. 1
• Do not use newer-generation antihistamines alone for non-allergic causes of post-nasal drip cough, as they lack anticholinergic activity and are ineffective. 1

---

When to Refer or Escalate

• If cough persists beyond 8 weeks despite systematic treatment of upper airway cough syndrome, asthma, and GERD, refer to a specialized cough clinic. 1
• Obtain a chest radiograph in chronic cough to exclude structural lung disease, malignancy, or tuberculosis. 1
• Red-flag symptoms requiring immediate re-evaluation include hemoptysis or progressive worsening of cough. 1